Stay updated on 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial
Sign up to get notified when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.

Latest updates to the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedTelix is conducting a separate Phase 3 trial (NCT06520345) under an IND, which necessitates the closure of the current 177Lu-TLX591-002 Phase 3 trial. The record now shows the study as Terminated and indicates that the prior Recruiting status was removed.SummaryDifference1.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedNew system Revision: v3.4.2 has been added to the record history, and the prior government funding lapse notice has been removed.SummaryDifference0.9%

- Check30 days agoChange DetectedA site-wide notice about government funding and an updated Revision: v3.4.1 were added, and the previous Revision: v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check37 days agoChange DetectedUI/formatting updates on the Record History page include a glossary toggle, color-coded highlights for additions and deletions, and a new version label (v3.4.0) replacing the previous (v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check51 days agoChange DetectedThe Record History now shows a new revision entry: v3.3.4, replacing the previous v3.3.3 entry.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 177Lu-DOTA-rosopatamab vs SoC in PSMA+ mCRPC: Clinical Trial page.